Biosenta Inc.
ZRO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 400.00 | 146.80K | 600.00 | 600.00 | 700.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.00 | 146.80K | 600.00 | 600.00 | 700.00 |
| Cost of Revenue | 500.00 | 500.00 | 3.00K | 3.00K | 3.00K |
| Gross Profit | 300.00 | 146.60K | -2.20K | -2.30K | -2.30K |
| SG&A Expenses | 778.20K | 840.60K | 928.60K | 1.05M | 1.05M |
| Depreciation & Amortization | 2.20K | 1.70K | 1.20K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 811.30K | 900.70K | 986.80K | 1.10M | 1.10M |
| Operating Income | -810.60K | -753.70K | -986.00K | -1.10M | -1.10M |
| Income Before Tax | -1.64M | -5.01M | -4.98M | -4.86M | -4.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.64 | -5.01 | -4.98 | -4.86 | -4.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.64M | -5.01M | -4.98M | -4.86M | -4.69M |
| EBIT | -810.60K | -753.70K | -986.00K | -1.10M | -1.10M |
| EBITDA | -626.90K | -271.00K | -137.00K | -- | -- |
| EPS Basic | -0.06 | -0.15 | -0.15 | -0.15 | -0.14 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.06 | -0.15 | -0.15 | -0.15 | -0.14 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 114.61M | 118.13M | 112.41M | 107.94M | 104.48M |
| Average Diluted Shares Outstanding | 114.61M | 118.13M | 112.41M | 107.94M | 104.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
